News Distribution & Press Release Service|Brand Story Press Wire
  • Brand Story Newswire
  • DIY – Price
  • PR Distribution
    • White Label PR
    • Law Firm PR
    • Blockchain Crypto NFT PR
    • Influencer PR
    • Get Featured in Large Media
    • Done With You
  • Existing Member: Login
  • New Member: Sign-Up
Menu
  • Brand Story Newswire
  • DIY – Price
  • PR Distribution
    • White Label PR
    • Law Firm PR
    • Blockchain Crypto NFT PR
    • Influencer PR
    • Get Featured in Large Media
    • Done With You
  • Existing Member: Login
  • New Member: Sign-Up
White Label Distribution
Book a Meeting
News Distribution & Press Release Service|Brand Story Press Wire

MENU

  • Brand Story Home
  • DIY – Price
  • PR Distribution
    • White Label PR
    • Law Firm PR
    • Blockchain Crypto NFT PR
    • Influencer PR
    • Get Featured in Large Media
    • Done For You
  • Existing Member: Login
  • Not a Member: Sign-Up
  • Book a Meeting
Menu
  • Brand Story Home
  • DIY – Price
  • PR Distribution
    • White Label PR
    • Law Firm PR
    • Blockchain Crypto NFT PR
    • Influencer PR
    • Get Featured in Large Media
    • Done For You
  • Existing Member: Login
  • Not a Member: Sign-Up
  • Book a Meeting

cbdMD'S Human Clinical Study Demonstrates Strong Pain Benefits – KISS PR Podcast

Published by Brand Story at November 17, 2022
News Distribution & Press Release Service | cbdMD'S Human Clinical Study Demonstrates Strong Pain Benefits – KISS PR Podcast
Categories
  • Podcast: Subject Matter Experts
Tags

News Distribution & Press Release Service | cbdMD'S Human Clinical Study Demonstrates Strong Pain Benefits – KISS PR Podcast

Initial Results from the First of Its Kind Clinical Study Demonstrate cbdMD's Proprietary Broad Spectrum Hemp Extract Reduces Pain in Healthy Adults.

Charlotte, North Carolina–(Newsfile Corp. – November 17, 2022) – cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces the first results from its recently concluded human clinical trial conducted at the University of South Carolina. These studies began in the fall of 2020 and the first results to be reported show the Company's proprietary broad spectrum hemp extract reduces pain in healthy adults. The ground breaking randomized, double blind, placebo controlled study was designed to explore the effects of cbdMD's proprietary broad spectrum cannabinoid blend on sleep, immunity, inflammation, mood, and pain in healthy adult subjects to further support the efficacy of the Company's products.

The Company and its subsidiary cbdMD Therapeutics, LLC will be releasing further results from the human clinical as they are finalized over the next few weeks and will eventually be publishing the results in a peer reviewed journal. The Company anticipates these favorable outcomes will form the basis for a number of future cbdMD product formulations. The study's results will also serve as preliminary data for additional future investigational studies executed by cbdMD's Therapeutics Division.

Study participants were given cbdMD's proprietary broad spectrum hemp extract blend containing 100 mg of CBD and other minor cannabinoids once per day for three months. The first results coming out of the study show that the perception and intensity of pain in healthy adults is significantly reduced with daily consumption of the Company's flagship broad spectrum blend. In anticipation of these results, the Company has recently launched a new flagship product in tincture, gummy and softgel which contains the clinically studied broad spectrum…

KISS PR Podcast Story Source link

Author

  • Brand Story
    Brand Story

    This is the "wpengine" admin user that our staff uses to gain access to your admin area to provide support and troubleshooting. It can only be accessed by a button in our secure log that auto generates a password and dumps that password after the staff member has logged in. We have taken extreme measures to ensure that our own user is not going to be misused to harm any of our clients sites.

    View all posts
Share

Related posts

January 8, 2024

Top Rated UK Reputation Management Consultant Steve O'Brien (SEO Chap) Interviewed by PR Expert Qamar Zaman – KISS PR Podcast


Read more
August 28, 2023

Spring Lake, North Carolina Dentist Dr. Maggie Youssef Interview by Qamar Zaman – KISS PR Podcast


Read more

Home Page

About Brand Story NEWSWIRE

Newsroom

Legal Policies

Press Release Guidelines

Resources

Crypto Investment Risks

Global Disclaimers

Press Release Distribution & Storytelling

PR Pricing for Business & Resellers

White Label Press Release for Agencies

Influencer & Earned Media PR

Law Firm PR & Personal Branding

Blockchain PR & Crypto Large Media Placements

Getting Placed in Major Publications

Send Press Release (DIY)

White Label Distribution

Done With You

Big Media / Tier 1 Guidelines

Yahoo Finance PR Guidelines

Business Insider PR Guidelines

AP News PR & Guest Post Guidelines

Wall Street Guidelines

MarketWatch Guidelines

Benzinga Guidelines

Forbes Story Guidelines

Morning Star PR Guidelines

Globe & Mail PR Guidelines

Member Login

Become a Member

Contact

News Distribution & Press Release Service | cbdMD'S Human Clinical Study Demonstrates Strong Pain Benefits – KISS PR Podcast

Digital Marketing & Data Journalism Company With Expertise in Storytelling

© 2025 - 2030 Storytellers Inc | Press Release Distribution to Google News | Yahoo, AP & 5000 News Websites | All Rights Reserved.

We are a Full Service Digital Marketing Company | Privacy Policy | Terms and Conditions

Facebook Google-plus-g Instagram Linkedin-in Rss
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.